- GWE significantly reduced PTSD and CPTSD symptoms versus waitlist at post-treatment, large effect sizes, maintained through 3-month follow-up.
- GWE also produced significant improvements in depression and affective and behavioural problems, while anxiety symptoms did not differ from waitlist.
- Five-session group delivery was feasible, with 92.6% retention, no adverse events, and potential scalability for low resource settings, warranting larger trials.
BMC Med. 2026 Aug 24;24(1):654. doi: 10.1186/s12916-026-05179-y.
ABSTRACT
BACKGROUND: Posttraumatic stress disorder (PTSD) is prevalent among adolescents, yet evidence-based treatments remain inaccessible to most. Complex PTSD (CPTSD), recently recognized in ICD-11, lacks empirical evidence to guide intervention in this population. Guided Written Exposure (GWE) is a brief, non-phased trauma-focused treatment with established efficacy in adults. This pilot trial evaluated the feasibility and preliminary efficacy of group-delivered GWE for adolescent PTSD and CPTSD.
METHODS: Fifty-three adolescents (aged 13-17) with PTSD symptoms following diverse trauma exposures were randomized to five-session group GWE (n = 27) or waitlist (n = 26). Primary outcomes were PTSD and CPTSD symptoms. Secondary outcomes included depression, anxiety, and affective and behavioral problems. Assessments occurred at baseline, post-intervention, 1-month, and 3-month (GWE only) follow-up. Treatment effects were analyzed using linear mixed-effects models.
RESULTS: GWE produced significantly greater reductions than waitlist in PTSD (d = – 1.15, 95% CI [- 1.89, – 0.41]) and CPTSD symptoms (d = – 0.97, 95% CI [- 1.70, – 0.23]) at post-treatment, with gains maintained through 3-month follow-up. Depression and affective and behavioral problems also improved significantly. Retention was high (92.6%) with no adverse events. Anxiety did not differ between groups.
CONCLUSIONS: Group-delivered GWE demonstrates promise as a brief, scalable intervention for posttraumatic stress symptoms, particularly in low-resource settings, and provides preliminary support that non-phased trauma-focused approaches may be feasible for adolescents with CPTSD. Replication in larger trials is warranted.
TRIAL REGISTRATION: ClinicalTrials.gov (NCT06403449). Registered on 3 May 2024.
PMID:43053131 | DOI:10.1186/s12916-026-05179-y
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

